Role of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in airway reactivity and inflammation in an allergic mouse model of asthma

References

• Reid IA, Morris BJ, Ganong WF. The renin–angiotensin system. Annu Rev Physiol. 1978;40:377–410.
   PubMed Web of Science ®Google Scholar
• Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37:1047–1052.
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation. 1994;89:493–498.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639–672.
   PubMed Web of Science ®Google Scholar
• Inagami T. The renin–angiotensin system. Essays Biochem. 1994;28:147–164.
   PubMed Web of Science ®Google Scholar
• Hein L, Meinel L, Pratt RE, et al. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 1997;11:1266–1277.
   PubMed Web of Science ®Google Scholar
• Catt KJ, Mendelsohn FA, Millan MA, et al. The role of angiotensin II receptors in vascular regulation. J Cardiovasc Pharmacol. 1984;6 Suppl 4:S575–S586.
   PubMedGoogle Scholar
• Ji Y, Liu J, Wang Z, et al. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem. 2009;23:265–276.
   PubMed Web of Science ®Google Scholar
• Lv J, Jia R, Yang D, et al. Candesartan attenuates angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway. Biochem Biophys Res Commun. 2009;380:81–86.
   PubMed Web of Science ®Google Scholar
• Marshall RP, Gohlke P, Chambers RC, et al. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004;286:L156–L164.
   PubMed Web of Science ®Google Scholar
• Phillips MI, Wang H, Kimura B, et al. Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge. Endocrinology. 1993;132:1637–1642.
   PubMed Web of Science ®Google Scholar
• Millar EA, Nally JE, Thomson NC. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur Respir J. 1995;8:1838–1841.
   PubMed Web of Science ®Google Scholar
• Endo Y, Arima S, Yaoita H, et al. Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int Suppl. 1997;63:S205–S207.
   PubMedGoogle Scholar
• Harada S, Nakata T, Oguni A, et al. Contrasting effects of angiotensin type 1 and 2 receptors on nitric oxide release under pressure. Hypertens Res. 2002;25:779–786.
   PubMed Web of Science ®Google Scholar
• Ponnoth DS, Nadeem A, Tilley S, et al. Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. Am J Physiol Heart Circ Physiol. 2010;299:H81–H87.
   PubMed Web of Science ®Google Scholar
• Munoz MC, Burghi V, Miquet JG, et al. Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice. Peptides. 2017;88:37–45.
   PubMed Web of Science ®Google Scholar
• Bivalacqua TJ, Dalal A, Lambert DG, et al. Effects of candesartan and PD123319 on responses to angiotensin II in the anesthetized mouse. J Am Soc Nephrol. 1999;10:S98–S100.
   PubMed Web of Science ®Google Scholar
• Wagenaar GTM, Sengers RMA, Laghmani EH, et al. Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats. Am J Physiol Lung Cell Mol Physiol. 2014;307:L261–L272.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Uehara S, Ohta H, et al. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice. Life Sci. 2004;75:869–880.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Yamauchi D, Yokoo M, et al. A potent hypotensive peptide, novokinin, induces relaxation by AT2- and IP-receptor-dependent mechanism in the mesenteric artery from SHRs. Biosci Biotechnol Biochem. 2008;72:257–259.
   PubMed Web of Science ®Google Scholar
• Oldenburg PJ, Mustafa SJ. Involvement of mast cells in adenosine-mediated bronchoconstriction and inflammation in an allergic mouse model. J Pharmacol Exp Ther. 2004;313:319–324.
   PubMed Web of Science ®Google Scholar
• Teng B, Ansari HR, Oldenburg PJ, et al. Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor-knockout mice. Am J Physiol Heart Circ Physiol. 2006;290:H1713–H1720.
   PubMed Web of Science ®Google Scholar
• Talukder MA, Morrison RR, Mustafa SJ. Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am J Physiol Heart Circ Physiol. 2002;282:H49–H57.
   PubMed Web of Science ®Google Scholar
• Braman SS. The global burden of asthma. Chest. 2006;130:4S–12S.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Ruiz-Ortega M, Lorenzo O, et al. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881–900.
   PubMed Web of Science ®Google Scholar
• Fyhrquist F, Saijonmaa O. Renin–angiotensin system revisited. J Intern Med. 2008;264:224–236.
   PubMed Web of Science ®Google Scholar
• Schulman IH, Raij L. The angiotensin II type 2 receptor: what is its clinical significance? Curr Hypertens Rep. 2008;10:188–193.
   PubMed Web of Science ®Google Scholar
• Esteban V, Lorenzo O, Rupérez M, et al. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol. 2004;15:1514–1529.
   PubMed Web of Science ®Google Scholar
• Chang Y, Wei W. Angiotensin II in inflammation, immunity and rheumatoid arthritis. Clin Exp Immunol. 2015;179:137–145.
   PubMed Web of Science ®Google Scholar
• Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205–251.
   PubMed Web of Science ®Google Scholar
• Yoshikawa M, Ohinata K, Yamada Y. The pharmacological effects of novokinin: a designed peptide agonist of the angiotensin AT2 receptor. Curr Pharm Des. 2013;19:3009–3012.
   PubMed Web of Science ®Google Scholar
• Drazen JM, Finn PW, De Sanctis GT. Mouse models of airway responsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators. Annu Rev Physiol. 1999;61:593–625.
   PubMed Web of Science ®Google Scholar
• Fan M, Mustafa SJ. Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pulm Pharmacol Ther. 2002;15:147–155.
   PubMed Web of Science ®Google Scholar
• Bosnjak B, Tilp C, Tomsic C, et al. Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice. Pulm Pharmacol Ther. 2014;27:44–51.
   PubMed Web of Science ®Google Scholar
• Rajavelu P, Chen G, Xu Y, et al. Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation. J Clin Invest. 2015;125:2021–2031.
   PubMed Web of Science ®Google Scholar
• Cheng B-H, Hu T-Y, Mo L-H, et al. Yan-Hou-Qing formula attenuates allergic airway inflammation via up-regulation of Treg and suppressing Th2 responses in ovalbumin-induced asthmatic mice. J Ethnopharmacol. 2019;231:275–282.
   PubMed Web of Science ®Google Scholar
• Low A, George S, Howard L, et al. Lung function, inflammation, and endothelin-1 in congenital heart disease-associated pulmonary arterial hypertension. J Am Heart Assoc. 2018;7(4): e007249.
   Web of Science ®Google Scholar
• El-Hashim AZ, Mathews S, Al-Shamlan F. Central adenosine A1 receptors inhibit cough via suppression of excitatory glutamatergic and tachykininergic neurotransmission. Br J Pharmacol. 2018;175:3162–3174.
   PubMed Web of Science ®Google Scholar
• Chen J-C, Tsai C-C, Hsieh C-C, et al. Multispecies probiotics combination prevents ovalbumin-induced airway hyperreactivity in mice. Allergol Immunopathol (Madr). 2018;46:354–360.
   PubMed Web of Science ®Google Scholar
• Jousilahti P, Salomaa V, Hakala K, et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol. 2002;89:381–385.
   PubMed Web of Science ®Google Scholar
• Duff JL, Marrero MB, Paxton WG, et al. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovasc Res. 1995;30:511–517.
   PubMed Web of Science ®Google Scholar
• Klahr S, Morrissey J. Angiotensin II and gene expression in the kidney. Am J Kidney Dis. 1998;31:171–176.
   PubMed Web of Science ®Google Scholar
• Bernstein KE, Ali MS, Sayeski PP, et al. New insights into the cellular signaling of seven transmembrane receptors: the role of tyrosine phosphorylation. Lab Invest. 1998;78:3–7.
   PubMed Web of Science ®Google Scholar
• Marrero MB, Schieffer B, Paxton WG, et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247–250.
   PubMed Web of Science ®Google Scholar
• Kay AB. The role of eosinophils in the pathogenesis of asthma. Trends Mol Med. 2005;11:148–152.
   PubMed Web of Science ®Google Scholar
• Trivedi SG, Lloyd CM. Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci. 2007;64:1269–1289.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033–1039.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Szefler SJ, Leung DYM, et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156:737–743.
   PubMed Web of Science ®Google Scholar
• Eschenbacher WL, Gravelyn TR. A technique for isolated airway segment lavage. Chest. 1987;92:105–109.
   PubMed Web of Science ®Google Scholar